Mr. Laur will oversee Cedars-Sinai’s Intellectual Property Company, a newly created entity, according to a March 7 LinkedIn post from Mr. Laur.
In this role, he will be responsible for the institution’s technology transfer- and intellectual property-related initiatives. He will also retain his role as managing director of Cedars-Sinai Health Ventures, the venture capital arm of the health system.
